RECRUITING

Impact of Hyperarch Fascia Training on Ankle Health and Exercise Performance

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this clinical trial is to evaluate whether the Hyperarch Fascia Training (HFT) program can reduce ankle pain and improve jump performance in active adults aged 20-45 with a history of ankle sprains. Participants will be randomly assigned to either an HFT intervention group or a control group, maintaining regular activity. Over 12 weeks, participants will complete remote training sessions, track jump performance using the "My Jump Lab" app, and complete ankle pain and stability questionnaires. All activities and assessments will be conducted remotely with guidance from certified coaches.

Official Title

The Impact of Hyperarch Fascia Training on Ankle Sprain Pain and Exercise Performance in Athletic Men and Women

Quick Facts

Study Start:2025-05-07
Study Completion:2025-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06959472

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:20 Years to 45 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Gender: Male or females
  2. * Age: 20-45 years old
  3. * History of Chronic Ankle Sprains has led to present symptoms such as current pain and/or instability during weight-bearing activities, but no reported chronic knee, hip, or groin issues (within the past 3-months).
  4. * Cumberland Ankle Instability Tool (CAIT) score ≤ 25, indicating significant instability in at least one ankle (Wright et al. 2014).
  5. * Participants will be either recreationally trained, or considered trained/developmental as defined by McKay et al. (2021). Specifically, recreationally trained will be defined as meeting the World Health Organization (WHO) minimum activity guidelines of: minimal activity of at least 150-300 minutes of moderate-intensity activity, or 75-150min of vigorous-intensity activity a week; plus, muscle-strengthening activities 2 or more days a week. Recreationally trained participants may also participate in multiple sports/forms of activity. Trained/developmental will be defined as regularly training \~3 times per week, identifying with a specific sport, training with a purpose to compete. There is no performance standard required for these tiers.
  6. * Health Status: Free from chronic diseases, cardiovascular conditions, and musculoskeletal injuries unrelated to ankle sprains.
  7. * Be willing to attend a weekly one hour virtual training session on HFT plus a written program to be performed individually in two sessions for an additional 2 hours per week performed on their own. In total, be willing to train for up to 3-5 hours weekly on ankle rehabilitation.
  8. * Agree to maintain their usual activity levels and avoid additional treatment modalities for the duration of the study.
  9. * Have a iPhone smart phone XR (2018), or later model
  10. * Have a desktop computer or laptop, with a camera for video conference calls and online training.
  11. * Have a location with a minimum of 10ft \* 10ft space for exercise movement, and appropriate ceiling height for vertical jump testing.
  1. * History of Achilles tendon rupture or surgery within the last 12 months. Use of prescribed corticosteroids or other tendon-specific treatments within four weeks prior to the study.
  2. * Current enrollment in any structured fascial or tendon rehabilitation programs.
  3. * Pregnancy, breastfeeding, or plans to become pregnant during the study period.
  4. * Any medical conditions that may interfere with running or exercise performance or study participation.
  5. * Not willing to sign an NDA regarding the fascia training techniques used in this study
  6. * Use of medical interventions, such as growth hormone or peptides, that may influence tissue adaptation to exercise.
  7. * Current supplementation with common soft-tissue ingredients, such as glucosamine, chondroitin, methylsufonylmethane (MSM), or collagen protein.
  8. * Presents with Ehlers-Danlos syndrome (EDS) or hypermobility History or current drug abuse
  9. * History or current cigarette smoke (including vaping) within the past 14 days from the screening visit
  10. * Insulin-dependent diabetes and/or metformin use
  11. * Chronic kidney or liver disease
  12. * Has significant concurrent illnesses (controlled or uncontrolled), such as diabetes, lupus, epilepsy, or cardiac disorders, hepatitis B/C, HIV, serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years, or other, which in the opinion of the investigator, such conditions might be aggravated as a result of treatment
  13. * Clinically diagnosed as depressed or taking depression or anti anxiety medication
  14. * The investigator feels that for any reason the subject is not eligible to participate in the study
  15. * History of uncontrolled cardiovascular disease (i.e., myocardial infarction, hypertension, hypercholesterolemia, peripheral vascular disease, other)
  16. * Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirement and/or record the necessary study measurements
  17. * Currently has been diagnosed with cancer or has been in remission for less than 1 year
  18. * Participation in any other investigational study within 30 days prior to consent.

Contacts and Locations

Study Contact

Charlie Ottinger, PhD
CONTACT
813-867-8888
cottinger@theaspi.com
Gabe Wilson, PhD
CONTACT
8138678888
gwilson@theaspi.com

Principal Investigator

Jacob Wilson, PhD
PRINCIPAL_INVESTIGATOR
Applied Science & Performance Institute

Study Locations (Sites)

Applied Science Performance Institute
Tampa, Florida, 33634
United States

Collaborators and Investigators

Sponsor: Applied Science & Performance Institute

  • Jacob Wilson, PhD, PRINCIPAL_INVESTIGATOR, Applied Science & Performance Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-07
Study Completion Date2025-10

Study Record Updates

Study Start Date2025-05-07
Study Completion Date2025-10

Terms related to this study

Keywords Provided by Researchers

  • ankle sprain
  • ankle injury
  • ankle pain
  • ankle instability
  • remote rehabilitation
  • countermovement jump

Additional Relevant MeSH Terms

  • Ankle Injuries
  • Sprains and Strains
  • Joint Instability